Teleflex Announces Launch of its Next Generation Vascular Positioning System®
The ARROW®VPS G4™Device providesaccurate and precise PICC placement
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYS: TFX) , a leading global provider of medical devices for critical care and surgery, announces the launch of the ARROW® VPS G4™Device. The ARROW VPS G4 Device is used in conjunction with the disposable ARROW® VPS® Stylet.
Using a combination of advanced technologies, the new ARROW VPS G4 Vascular Positioning System allows a clinician to accurately and precisely place a peripherally inserted central catheter (PICC) or central venous catheter (CVC) in the optimal spot in the superior vena cava, based on the Infusion Nursing Society (INS) guidelines. PICCs and CVCs are used to deliver vital therapeutics to critically ill patients. The technology is designed to avoid clinical consequences such as thrombosis, arterial puncture and vessel wall damage.
"Accurately assessing the correct tip placement of a central line can be difficult and has always required chest X-ray confirmation," states Bradley B. Hill, MD, Vascular Surgeon and co-inventor of the VPS® Technology. "The ARROW VPS Technology has the ability to provide immediate and simple confirmation, eliminating the need for costly and time-consuming X-rays. It also reduces the risk of complications associated with malposition. With this system, patients can receive vital therapies faster, putting them on the path to recovery sooner."
The ARROW VPS G4 Device employs a simple user interface and easy-to-interpret symbols, including the Blue Bullseye symbol that indicates optimal catheter tip placement. New features of the ARROW VPS G4 Device include state-of-the-art design and technology, such as statement of final catheter position, enhanced sterile field capability, and Wi-Fi access allowing integration to hospital data management systems.
"This is our newest addition of the powerful VPS® Tip placement engine, completely redesigned for ease of use and functionality. It is a compilation of leading edge technologies for improved patient outcomes. The VPS G4 is aimed at making zero complications in vascular access a reality," said Paul Molloy, President Vascular Access Division, Teleflex Incorporated.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, Pa, Teleflex employs approximately 11,700 people worldwide and serves healthcare providers in more than 140 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Bradley B. Hill, MD is a paid consultant of Teleflex and a former shareholder of VasoNova, Inc., developer of the VPS technology acquired by Teleflex in 2011. As a former shareholder of VasoNova, Dr. Hill may be entitled to receive additional consideration from Teleflex if certain VPS sales milestones are achieved.
Teleflex, Arrow, Vascular Positioning System, VPS and VPS G4 are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.
© 2013 All rights reserved. Teleflex Incorporated. 2013-2061.
Treasurer and Vice President, Investor Relations
KEYWORDS: United States North America Pennsylvania
The article Teleflex Announces Launch of its Next Generation Vascular Positioning System® originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.